zsuzsanna suba

Summary

Publications

  1. pmc Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
    Zsuzsanna Suba
    National Institute of Oncology, Surgical and Molecular Tumor Pathology Centre, Address H 1122, Ráth György Str 7 9, Budapest, Hungary
    Recent Pat Anticancer Drug Discov 11:254-66. 2016
  2. pmc Circulatory estrogen level protects against breast cancer in obese women
    Zsuzsanna Suba
    National Institute of Oncology, Surgical and Molecular Tumor Pathology Centre, Address H 1122 Rath Gyorgy str 7 9, Budapest, Hungary
    Recent Pat Anticancer Drug Discov 8:154-67. 2013
  3. ncbi request reprint Light deficiency confers breast cancer risk by endocrine disorders
    Zsuzsanna Suba
    National Institute of Oncology, Surgical and Molecular Tumor Pathology Centre, 1122 Ráth György u 7 9, Budapest, Hungary
    Recent Pat Anticancer Drug Discov 7:337-44. 2012
  4. doi request reprint Interplay between insulin resistance and estrogen deficiency as co- activators in carcinogenesis
    Zsuzsanna Suba
    National Institute of Oncology, 1122 Ráth György u 7 9, Budapest, Hungary
    Pathol Oncol Res 18:123-33. 2012
  5. doi request reprint [Interactions of insulin and estrogen in the regulation of cell proliferation and carcinogenesis]
    Zsuzsanna Suba
    Országos Onkológiai Intézet Sebészeti és Molekuláris Tumorpatológiai Osztály Budapest Ráth György u
    Orv Hetil 153:125-36. 2012

Detail Information

Publications6

  1. pmc Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery
    Zsuzsanna Suba
    National Institute of Oncology, Surgical and Molecular Tumor Pathology Centre, Address H 1122, Ráth György Str 7 9, Budapest, Hungary
    Recent Pat Anticancer Drug Discov 11:254-66. 2016
    ..Results of long-term studies justify that the rate of breast cancer recurrence and tumor-related mortality remains quite unpredictable, regardless of the use of any current therapeutic measures...
  2. pmc Circulatory estrogen level protects against breast cancer in obese women
    Zsuzsanna Suba
    National Institute of Oncology, Surgical and Molecular Tumor Pathology Centre, Address H 1122 Rath Gyorgy str 7 9, Budapest, Hungary
    Recent Pat Anticancer Drug Discov 8:154-67. 2013
    ..New patents recommend various methods for the prevention and treatment of obesity-related systemic disorders and the associated breast cancer...
  3. ncbi request reprint Light deficiency confers breast cancer risk by endocrine disorders
    Zsuzsanna Suba
    National Institute of Oncology, Surgical and Molecular Tumor Pathology Centre, 1122 Ráth György u 7 9, Budapest, Hungary
    Recent Pat Anticancer Drug Discov 7:337-44. 2012
    ..Recent patents provide new methods for the prevention of hormonal and metabolic abnormities...
  4. doi request reprint Interplay between insulin resistance and estrogen deficiency as co- activators in carcinogenesis
    Zsuzsanna Suba
    National Institute of Oncology, 1122 Ráth György u 7 9, Budapest, Hungary
    Pathol Oncol Res 18:123-33. 2012
    ..Moreover, their interactions in the initiation and progression of human malignancies may supply new strategies in primary cancer prevention and cancer cure...
  5. doi request reprint [Interactions of insulin and estrogen in the regulation of cell proliferation and carcinogenesis]
    Zsuzsanna Suba
    Országos Onkológiai Intézet Sebészeti és Molekuláris Tumorpatológiai Osztály Budapest Ráth György u
    Orv Hetil 153:125-36. 2012
    ..In patients with cancer the treatment of hormonal and metabolic disturbances may become effective adjuvant therapy...